Dysphonia

Phase 4 trials (3)

• pyridostigmine bromide
• lansoprazole
• omeprazole

Phase 3 trials (3)

• sodium oxybate
• ketorolac
• dexamethasone

Phase 2 trials (5)

• azficel-T
• daxibotulinumtoxinA
• onabotulinumtoxinA
• zinc gluconate
• msc-ki-pl-204

Phase 1 trials (1)

• bupivacaine

Other trials (7)

• methylprednisolone
• prednisone
• lactose
• lidocaine
• epinephrine
• artemisia
• tea

Organization Involved with Phase 4 Indications (4)

• TAP Pharmaceuticals
• Medical University of Lodz
• University of Kansas
• B.P. Koirala Institute of Health Sciences

Organization Involved with Phase 3 Indications (5)

• National Institute on Deafness and Other Communication Disorders (NIDCD)
• Massachusetts Eye and Ear Infirmary
• Azad University
• Harvard University
• Isfahan University

Organization Involved with Phase 2 Indications (4)

• Fibrocell Technologies, Inc.
• University of California, Los Angeles
• Karolinska Institute
• Swedish Foundation for Strategic Research

Organization Involved with Other Experimental Indications (7)

• National Institutes of Health (NIH)
• Banner Health
• University of Arizona
• New York University
• Mayo Clinic
• Icahn School of Medicine at Mount Sinai
• More Foundation